Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Santosha A. Vardhana(Memorial Sloan Kettering Cancer Center)
Nature Medicine
June 17, 2024
Cited by 39


Related Papers

No related papers found

Powered by citation graph analysis